Homocysteine and Methylmalonic Acid

General

Synonym/Acronym:
N/A

Rationale
To assist in evaluating increased risk for blood clots, plaque formation, and platelet aggregations associated with atherosclerosis and stroke risk.

Patient Preparation
There are no food, fluid, activity, or medication restrictions unless by medical direction.

Normal Findings
Method: Enzymatic for homocysteine; liquid chromatography tandem mass spectrometry for methylmalonic acid

Conventional and SI Units
Homocysteine Less than 15 micromol/L
Methylmalonic acid Less than 0.4 micromol/L


Critical Findings and Potential Interventions
N/A

There's more to see -- the rest of this topic is available only to subscribers.